Biblio Discovery — Demo Discovery Service

15 hasil untuk "Arjun Rustagi"

Menampilkan 1–15 · 1,29 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Evaluating the Utility of UV Lamps to Mitigate the Spread of Pathogens in the ICU

    Andrew Gostine; David Gostine; Jack Short dkk.

    Applied Sciences, Vol. 10 No. 18 · 2020 · Inggris · DOAJ Scopus

    Contaminated surfaces in a hospital serve as reservoirs for pathogen spread. The aim of this study was to evaluate UV lights in preventing the spread of a DNA tracer in an intensive care unit (ICU) through sterilization of highly touched surfaces. In a prospective trial, a non-pathogenic DNA virus…

  2. Artikel Jurnal

    Resistance of endothelial cells to SARS-CoV-2 infection in vitro

    Blerina Ahmetaj-Shala; Thomas P. Peacock; Laury Baillon dkk.

    Journal of Virology, Vol. 99 No. 12 · 2025 · Inggris · DOAJ Scopus

    ABSTRACT The secondary thrombotic/vascular clinical syndrome of COVID-19 suggests that SARS-CoV-2 infects the endothelium; however, robust in vitro infection of endothelial cells by various strains of SARS-CoV-2 remains to be demonstrated and continues to be debated. Here, we revisit the question…

  3. Artikel Jurnal Teks lengkap

    Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis

    Jennifer G. Wilson; Laura J. Simpson; Anne-Maud Ferreira dkk.

    JCI Insight · 2020 · Inggris · OpenAlex Scopus

    BACKGROUNDElevated levels of inflammatory cytokines have been associated with poor outcomes among COVID-19 patients. It is unknown, however, how these levels compare with those observed in critically ill patients with acute respiratory distress syndrome (ARDS) or sepsis due to other…

    Juga tersedia di: DOAJ

  4. Artikel Jurnal Teks lengkap

    The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters

    Timothy Carroll; Douglas Fox; Neeltje van Doremalen dkk.

    PLOS Pathogens, Vol. 18 No. 2 · 2022 · Inggris · PLOS Scopus

    As novel SARS-CoV-2 variants continue to emerge, it is critical that their potential to cause severe disease and evade vaccine-induced immunity is rapidly assessed in humans and studied in animal models. In early January 2021, a novel SARS-CoV-2 variant designated B.1.429 comprising 2 lineages…

    Juga tersedia di: DOAJ

  5. Artikel Jurnal Teks lengkap

    Membrane-wide screening identifies potential tissue-specific determinants of SARS-CoV-2 tropism

    Ravi K. Dinesh; Chengkun Wang; Yuanhao Qu dkk.

    PLOS Pathogens, Vol. 21 No. 7 · 2025 · Inggris · PLOS Scopus

    While SARS-CoV-2 primarily infects the respiratory tract, clinical evidence indicates that cells from diverse cell types and organs are also susceptible to infection. Using the CRISPR activation (CRISPRa) approach, we systematically targeted human membrane proteins in cells with and without…

    Juga tersedia di: DOAJ

  6. Artikel Jurnal

    Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome

    Katharina Röltgen; Abigail E. Powell; Oliver Fabian Wirz dkk.

    Science Immunology · 2020 · Inggris · OpenAlex Scopus

    SARS-CoV-2-specific antibodies, particularly those preventing viral spike receptor binding domain (RBD) interaction with host angiotensin-converting enzyme 2 (ACE2) receptor, can neutralize the virus. It is, however, unknown which features of the serological response may affect clinical outcomes of…

  7. Artikel Jurnal

    An intranasal ASO therapeutic targeting SARS-CoV-2

    Chi Zhu; Justin Y. Lee; Jia Z. Woo dkk.

    Nature Communications, Vol. 13 No. 1 · 2022 · Inggris · DOAJ Scopus

    Abstract The COVID-19 pandemic is exacting an increasing toll worldwide, with new SARS-CoV-2 variants emerging that exhibit higher infectivity rates and that may partially evade vaccine and antibody immunity. Rapid deployment of non-invasive therapeutic avenues capable of preventing infection by…

  8. Artikel Jurnal

    Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitro

    Leiping Zeng; Yanxia Liu; Xammy Huu Wrynla dkk.

    Nature Communications, Vol. 13 No. 1 · 2022 · Inggris · DOAJ Scopus

    Abstract A major challenge in coronavirus vaccination and treatment is to counteract rapid viral evolution and mutations. Here we demonstrate that CRISPR-Cas13d offers a broad-spectrum antiviral (BSA) to inhibit many SARS-CoV-2 variants and diverse human coronavirus strains with >99% reduction of…

  9. Artikel Jurnal Teks lengkap

    Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19

    Aaron J. Wilk; Madeline J. Lee; Bei Wei dkk.

    The Journal of Experimental Medicine · 2021 · Inggris · OpenAlex Scopus

    Our understanding of protective versus pathological immune responses to SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), is limited by inadequate profiling of patients at the extremes of the disease severity spectrum. Here, we performed multi-omic single-cell immune profiling…